Novartis AG (NVS)
94.36
+1.79
(+1.93%)
USD |
NYSE |
Apr 19, 16:00
94.36
0.00 (0.00%)
After-Hours: 20:00
Novartis Free Cash Flow: 11.70B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.70B |
| September 30, 2023 | 13.55B |
| June 30, 2023 | 13.10B |
| March 31, 2023 | 13.69B |
| December 31, 2022 | 12.00B |
| September 30, 2022 | 11.71B |
| June 30, 2022 | 11.67B |
| March 31, 2022 | 12.03B |
| December 31, 2021 | 12.52B |
| September 30, 2021 | 12.18B |
| June 30, 2021 | 10.32B |
| March 31, 2021 | 10.29B |
| December 31, 2020 | 11.06B |
| September 30, 2020 | 10.99B |
| June 30, 2020 | 12.46B |
| March 31, 2020 | 11.46B |
| December 31, 2019 | 11.37B |
| September 30, 2019 | 11.58B |
| June 30, 2019 | 10.79B |
| March 31, 2019 | 11.74B |
| December 31, 2018 | 11.62B |
| September 30, 2018 | 11.40B |
| June 30, 2018 | 11.11B |
| March 31, 2018 | 10.68B |
| December 31, 2017 | 10.33B |
| Date | Value |
|---|---|
| September 30, 2017 | 10.25B |
| June 30, 2017 | 9.847B |
| March 31, 2017 | 9.254B |
| December 31, 2016 | 8.596B |
| September 30, 2016 | 8.975B |
| June 30, 2016 | 8.804B |
| March 31, 2016 | 8.236B |
| December 31, 2015 | 8.392B |
| September 30, 2015 | 9.573B |
| June 30, 2015 | 10.24B |
| March 31, 2015 | 10.75B |
| December 31, 2014 | 10.49B |
| September 30, 2014 | 9.497B |
| June 30, 2014 | 9.985B |
| March 31, 2014 | 9.351B |
| December 31, 2013 | 9.796B |
| September 30, 2013 | 10.37B |
| June 30, 2013 | 10.18B |
| March 31, 2013 | 10.71B |
| December 31, 2012 | 11.42B |
| September 30, 2012 | 11.52B |
| June 30, 2012 | 11.86B |
| March 31, 2012 | 12.41B |
| December 31, 2011 | 11.92B |
| September 30, 2011 | 11.71B |
Free Cash Flow Range, Past 5 Years
10.29B
Minimum
Mar 2021
13.69B
Maximum
Mar 2023
11.81B
Average
11.70B
Median
Dec 2023
Free Cash Flow Benchmarks
| Sandoz Group AG | -- |
| Roche Holding AG | 12.82B |
| Amgen Inc | 7.359B |
| Incyte Corp | 449.00M |
| MorphoSys AG | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.547B |
| Cash from Investing (Quarterly) | -1.76B |
| Cash from Financing (Quarterly) | -607.00M |
| Free Cash Flow Per Share (Quarterly) | 0.8505 |
| Free Cash Flow to Equity (Quarterly) | 770.00M |
| Free Cash Flow to Firm (Quarterly) | 1.764B |
| Free Cash Flow Yield | 5.93% |